---
title: "Deccan Health Care Ltd (542248) — Share Price, Financials & Analysis"
symbol: "542248"
company: "Deccan Health Care Ltd"
canonical: "https://tapetide.com/stocks/542248"
isin: "INE452W01019"
nse_symbol: "DECCANHEALTHCARELTD"
bse_code: "542248"
sector: "Healthcare Services"
industry: "Healthcare Service Provider"
market_cap_cr: 28.81
generated_at: "2026-09-13T18:38:01.996Z"
---

# Deccan Health Care Ltd (542248)

Canonical page: https://tapetide.com/stocks/542248

## Company

- **NSE Symbol:** DECCANHEALTHCARELTD
- **BSE Code:** 542248
- **ISIN:** INE452W01019
- **Sector:** Healthcare Services
- **Industry:** Healthcare Service Provider
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2018-12-31
- **CEO:** Dr. Minto Purshotam Gupta
- **Employees:** 83
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** deccanhealthcare.co.in

## About

Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer  health products[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:43:11.660151Z.

- **Market Cap:** ₹28.81 Cr
- **Classification:** Microcap
- **P/E (reported):** 11.9
- **EPS (TTM):** ₹1.02
- **EPS (reported):** ₹0.76
- **Book Value:** ₹44.55
- **Price to Book:** 0.27
- **Dividend Yield:** 0%
- **ROE:** 1.09%
- **ROCE:** 1.56%
- **Debt to Equity:** 0.04
- **Revenue (yearly):** ₹81.9 Cr
- **Net Income:** ₹2.37 Cr
- **EBITDA:** ₹5.08 Cr
- **52-Week High:** ₹21.2
- **52-Week Low:** ₹6.65
- **RSI (14):** 39.73

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Falling
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 64.97 | 9% |
| growth | 36.92 | 9% |
| momentum | 45.24 | 12% |
| ownership | 50 | 24% |
| quality | 28.11 | 22% |
| valuation | 63.89 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.28 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 19.5%
- Company has a low return on equity of 1.72% over last 3 years.
- Contingent liabilities of Rs.16.8 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 48.76% | 4.88% | — |
| ebitda margin growth | 0% | 47.27% | -1.59% | -62.81% |
| net income growth | 0% | 97.5% | 100% | 45% |
| revenue growth | 5.24% | 9.05% | 22% | 19% |
| roce | 7.84% | -31.88% | 140% | 1.23% |
| roe | -12.12% | -29.22% | 1% | 113.73% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 17.19 | 15.34 | 15.97 | 15.06 | 18.82 | 20.43 | 20.75 | 22.14 | 21.4 | 17.39 | 20.98 | 22.07 |
| Expenses | 16.15 | 14.11 | 15.3 | 14.19 | 17.71 | 19.84 | 20.14 | 21.39 | 19.69 | 15.66 | 20.09 | 21.17 |
| Operating Profit | 1.04 | 1.23 | 0.67 | 0.87 | 1.11 | 0.59 | 0.61 | 0.75 | 1.71 | 1.73 | 0.89 | 0.9 |
| OPM % | 6.05 | 8.02 | 4.2 | 5.78 | 5.9 | 2.89 | 2.94 | 3.39 | 7.99 | 9.95 | 4.24 | 4.08 |
| Other Income | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.03 |
| Interest | 0 | 0.04 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.16 | 0.04 | 0.14 | 0.16 |
| Depreciation | 0.32 | 0.4 | 0.36 | 0.36 | 0.37 | 0.37 | 0.36 | 0.41 | 0.33 | 0.35 | 0.38 | 0.39 |
| Profit before tax | 0.72 | 0.79 | 0.3 | 0.49 | 0.71 | 0.2 | 0.23 | 0.33 | 1.22 | 1.34 | 0.37 | 0.38 |
| Tax % | 25 | 32.91 | 60 | 26.53 | 25.35 | 25 | 47.83 | 30.3 | 25.41 | 25.37 | 8.11 | 23.68 |
| Net Profit | 0.54 | 0.53 | 0.13 | 0.36 | 0.53 | 0.14 | 0.12 | 0.24 | 0.91 | 1 | 0.33 | 0.29 |
| EPS in Rs | 0.32 | 0.26 | 0.06 | 0.18 | 0.25 | 0.06 | 0.05 | 0.1 | 0.37 | 0.4 | 0.13 | 0.12 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.06 | 81.9 | 81.84 |
| Expenses | 30.57 | 31.74 | 27.54 | 43.06 | 55.97 | 71.92 | 76.81 | 76.61 |
| Operating Profit | 11.67 | 2.04 | 5.63 | 1.96 | 3.76 | 3.14 | 5.09 | 5.23 |
| OPM % | 27.63 | 6.04 | 16.97 | 4.35 | 6.29 | 4.18 | 6.21 | 6.39 |
| Other Income | 0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 |
| Interest | 0.18 | 0.11 | 0.15 | 0.11 | 0.09 | 0.07 | 0.37 | 0.5 |
| Depreciation | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.46 | 1.45 |
| Profit before tax | 10.13 | 0.52 | 0.55 | 0.44 | 2.21 | 1.63 | 3.27 | 3.31 |
| Tax % | 0.39 | 25 | 40 | 31.82 | 33.03 | 28.83 | 23.85 | — |
| Net Profit | 10.09 | 0.39 | 0.32 | 0.31 | 1.49 | 1.16 | 2.49 | 2.53 |
| EPS in Rs | 6.42 | 0.25 | 0.2 | 0.18 | 0.73 | 0.5 | 1.01 | 1.02 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 | 24.75 |
| Reserves | 60.52 | 60.91 | 61.23 | 64.52 | 76.53 | 82.97 | 85.51 |
| Borrowings | 0.87 | 1.03 | 1.25 | 1.61 | 1.9 | 1.15 | 3.96 |
| Other Liabilities | 15.89 | 14.61 | 12.44 | 13.62 | 9.24 | 17.38 | 34.69 |
| Total Liabilities | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 | 148.91 |
| Fixed Assets | 21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | 15.02 |
| CWIP | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 |
| Investments | 37.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 33.84 | 72.32 | 72.1 | 79.94 | 92.36 | 110.55 | 133.89 |
| Total Assets | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 | 148.91 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2.68 | 0.22 | -0.57 | -6.76 | -12.55 | -6.43 | -3.62 |
| Cash from Investing Activity | -1.94 | -0.07 | -0.05 | 0.27 | -0.3 | -0.14 | -2.25 |
| Cash from Financing Activity | -1.77 | -0.37 | 0.07 | 5.26 | 14.04 | 7.52 | 3.96 |
| Net Cash Flow | -1.03 | -0.22 | -0.56 | -1.23 | 1.19 | 0.95 | -1.91 |
| Free Cash Flow | 0.87 | 0.06 | -0.63 | -6.51 | -12.86 | -6.57 | -5.86 |
| CFO/OP | 23 | 18 | -6 | -334 | -311 | -204 | -71 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 60.98 | 75.72 |
| Inventory Days | 0 | 890.81 | 1182.75 | 683.64 | 445.05 | 327.35 | 340.22 |
| Days Payable | — | 112.09 | 147.78 | 123.28 | 41.68 | 69 | 143.23 |
| Cash Conversion Cycle | 177.66 | 913.46 | 1176.04 | 657.58 | 463.81 | 319.32 | 272.71 |
| Working Capital Days | 421.77 | 545.99 | 603.01 | 507.69 | 477.19 | 423.01 | 418.97 |
| ROCE % | — | 0.81 | 5.62 | 0.68 | 2.53 | 1.65 | 3.28 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 19.27% | 16.12% | 16.12% | 16.12% | 15.66% | 18.26% | 19.46% | 18.42% | 18.42% | 18.42% | 19.46% | 19.46% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 7.8% | 0% | 6.53% | 6.53% | 6.34% | 5.87% | 5.68% | 5.37% | 5.37% | 5.37% | 5.68% | 5.68% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 58.54% | 48.93% | 52.31% | 50.78% | 49.44% | 48.92% | 47.83% | 46.53% | 46.4% | 46.36% | 53.97% | 54.09% |
| Others | 14.38% | 34.95% | 25.05% | 26.57% | 28.57% | 26.95% | 27.03% | 29.68% | 29.81% | 29.84% | 20.89% | 20.77% |
| No. of Shareholders | 1645 | 2041 | 2737 | 3002 | 3154 | 3416 | 3614 | 3667 | 3743 | 3926 | 4004 | 4084 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 7 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 12.55 | Sell |
| EMA (10) | 12.55 | Sell |
| SMA (20) | 12.83 | Sell |
| EMA (20) | 12.71 | Sell |
| SMA (50) | 12.91 | Sell |
| EMA (50) | 12.81 | Sell |
| SMA (100) | 12.79 | Sell |
| EMA (100) | 12.9 | Sell |
| SMA (200) | 13.13 | Sell |
| EMA (200) | 13.79 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.24 | Neutral |
| MACD (12,26,9) | -0.16 | Sell |
| Stochastic (14,3,3) | 31.74 | Neutral |
| ADX (14) | 8.06 | Neutral |
| Williams %R (14) | -56.99 | Neutral |
| ATR (14) | 0.82 | High Volatility |
| ROC (12) | -5.32 | Sell |
| Stoch RSI (14) | 35.68 | Neutral |
| UO (7,14,28) | 66.57 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b3c4dfe-d9bf-4c5b-be45-40936780e3ae.pdf) |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76a8e884-dabf-43e4-b9e8-0114d0b0a5ab.pdf) |
| 2026-09-07 | [Notice Of 30Th Annual General Meeting Of Deccan Health Care Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c001f3b5-3652-422b-8425-2299b76eb779.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=285007d2-a332-4642-a4a9-cce30d49eb76.pdf) |
| 2026-09-07 | [Notice Of Book Closure And Cut-Off Date For E-Voting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=530594f7-c5a1-4db3-8c73-ee30f198824a.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8a4c99d-87f5-4c9f-819e-1228dc57d8d1.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a17c979-aad5-4f8d-acee-1c2d65f56a52.pdf) |
| 2026-08-06 | [Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30Th 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e0bfa10-109d-4649-b10f-8afd90468904.pdf) |
| 2026-07-27 | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1366ae0f-2e1a-4d84-a297-120596c1c762.pdf) |
| 2026-07-24 | [Shareholder Meeting / Postal Ballot-Outcome of EGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=845615b9-c003-4d46-8360-dc611f2f4c85.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Un-Audited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4dadc4-860b-461d-8376-a171f2dcb23b.pdf) |
| 2026-05-30 | [Audited Standalone And Consolidated Results For FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5aced354-4b30-42ad-adf0-e8f0d7289eed.pdf) |
| 2025-11-14 | [Approval Of Unaudited Financial Results For Quarter Ended Sep-25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10e7b311-a29d-440f-8be0-4fb62acae860.pdf) |
| 2025-08-14 | [Results For The Quarter Ended June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6656dd33-b581-4bed-9d79-bd0e2d2e642b.pdf) |
| 2025-05-29 | [Results For The Financial Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4443129-66a3-4160-870c-38ce2a3e93ae.pdf) |
| 2025-02-14 | [Quarter Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2658cf68-6f35-4244-9378-1bfdcb80b39a.pdf) |
| 2024-11-14 | [Financial Results For The Quarter Ended 30 September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=071d4109-3dcd-4223-9d70-7d7c22999e59.pdf) |
| 2024-07-31 | [Financial Result June 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e316c078-6821-4d6c-b4b3-876a0a6dbe03.pdf) |
| 2024-05-29 | [Financial Results For The Quarter And Year Ended 31St March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73ae2ecb-4b92-4b73-9c2b-c24201f2815b.pdf) |
| 2024-02-06 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. February 06, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fd3b248-3bd1-4911-8d3e-9abc13a28990.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Ms. Shikha Das appointed Company Secretary and Compliance Officer on 25.04.2026. | [Appointment of Company Secretary and Compliance Officer 9h - Ms. Shikha Das appointed Company Secretary and Compliance Officer on 25.04.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0b3ed138-4eea-453e-8a7f-b68c2932d483.pdf) |
| 9h - Deccan Healthcare appointed three independent directors on the board on 25.04.2026. | [Announcement under Regulation 30 (LODR)-Change in Management 9h - Deccan Healthcare appointed three independent directors on the board on 25.04.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/66deedf5-fdfa-4990-b738-e35b980f60e8.pdf) |
| 9h - Deccan Health Care reports wellness growth, opens 20 Wellness Marts, plans 30 more, and expands into hydration and sports nutrition. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 9h - Deccan Health Care reports wellness growth, opens 20 Wellness Marts, plans 30 more, and expands into hydration and sports nutrition.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d67e9f2d-a59a-490d-a966-fbcbe94dd60a.pdf) |
| 30 Apr - 30 Apr 2026 press release published on wellness expansion into hydration and sports nutrition. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - 30 Apr 2026 press release published on wellness expansion into hydration and sports nutrition.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/40a5a98a-10a8-4ca1-8c67-29454b96d4ef.pdf) |
| 30 Apr - 30 Apr 2026 press release published on wellness expansion into hydration and sports nutrition. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - 30 Apr 2026 press release published on wellness expansion into hydration and sports nutrition.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/40a5a98a-10a8-4ca1-8c67-29454b96d4ef.pdf) |
| 25 Apr - Ms. Shikha Das appointed Company Secretary and Compliance Officer on 25.04.2026. | [Appointment of Company Secretary and Compliance Officer 25 Apr - Ms. Shikha Das appointed Company Secretary and Compliance Officer on 25.04.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b3ed138-4eea-453e-8a7f-b68c2932d483.pdf) |
| 25 Apr - Deccan Healthcare appointed three independent directors on the board on 25.04.2026. | [Announcement under Regulation 30 (LODR)-Change in Management 25 Apr - Deccan Healthcare appointed three independent directors on the board on 25.04.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/66deedf5-fdfa-4990-b738-e35b980f60e8.pdf) |
| 25 Apr - Deccan Health Care reports wellness growth, opens 20 Wellness Marts, plans 30 more, and expands into hydration and sports nutrition. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 25 Apr - Deccan Health Care reports wellness growth, opens 20 Wellness Marts, plans 30 more, and expands into hydration and sports nutrition.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d67e9f2d-a59a-490d-a966-fbcbe94dd60a.pdf) |
| 2 Mar - Investor presentation dated 2 Mar 2026; order book INR 44,910 Mn; Q3 FY26 intake INR 9,140 Mn. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 2 Mar - Investor presentation dated 2 Mar 2026; order book INR 44,910 Mn; Q3 FY26 intake INR 9,140 Mn.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3309865-d69d-43e9-9ba4-c9b6056f5f78.pdf) |
| 17 Feb - Q3 FY26: revenue Rs8.41bn; exceptional Rs3,344m gratuity charge; order intake Rs9.14bn; CCUS and Rs100cr+ orders | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 17 Feb - Q3 FY26: revenue Rs8.41bn; exceptional Rs3,344m gratuity charge; order intake Rs9.14bn; CCUS and Rs100cr+ orders](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b281197f-cff6-4c85-abba-4743d8455903.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6b0473fc-dce5-46b0-96fc-15471d5e65d0.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8e6efe2-e315-4e52-9be0-d29e9230bb66.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5f9572c9-c5aa-4932-93c8-6af2153f44b2.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a38027df-eae7-490d-86ab-ead975395d0d.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3f7471eb-9e7d-465a-9cde-d417882ebe05.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8008a4d1-90c8-4af7-8a5b-f19b8f664d3f.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/86039320-39b0-4f85-b1cb-4879df5d94c3.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://nsearchives.nseindia.com/corporate/PRAJIND_07112023213100_TranscriptsAnalystsCall01112023.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8f4dfb36-f1b2-4d4a-9eb6-44aaaeb369f7.pdf) |
| May 2024 | [Concall - May 2024](https://nsearchives.nseindia.com/corporate/PRAJIND_30052024224008_PresentationAFR30052024.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2025-11-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f9572c9-c5aa-4932-93c8-6af2153f44b2.pdf) |
| 2024-11-15 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f7471eb-9e7d-465a-9cde-d417882ebe05.pdf) |
| 2024-08-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fe59a3b-e1e2-4b73-a9c9-d0fc501d341a.pdf) |
| 2024-06-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54e239d0-bca3-4463-905d-1c55e043f78b.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_191_PRAJIND_2012_2013_01072013174422.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/282c694f-406b-42a5-9d86-3c443686d7d1.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2519ddcc-263a-490e-966b-a8c797fab3cc.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/223b3e0d-ebea-475b-93e9-9ff271269239.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/502cb127-ff97-4371-8abe-da0ec3751bf9.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7c47fec8-8625-4543-ae18-a4b940c58ccb.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4d744188-7bc9-4386-8639-d1706a5d97c1.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/542248/75703542248.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/522205/73652522205.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/542248/71743542248.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:38:01.996Z.